DOS-UGA-SMGCG-FY25: PEPFAR Uganda Community Grants to Combat HIV/AIDS
Closed
This grant is closed. A newer notice from the same program is open now: Advancing Global Health (DFOP0017890). Status: Closes February 14, 2027 (99 days left). It is in our archive of Bureau of African Affairs notices from 2024.
Bureau of African Affairs offered grants of up to $15,000 (at least $5,000) to nonprofits. It expected to make about 15 awards worth $310,000 in total. Applications closed on July 31, 2024.
From the official notice on Grants.gov, last changed June 12, 2024. Checked November 7, 2026.
- Award ceiling$15,000
- Award floor$5,000
- Total funding$310,000
- Expected awards15
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | June 12, 2024 |
|---|---|
| Deadline | July 31, 2024 |
| Archived by Grants.gov | August 30, 2024 |
Who can apply
This opportunity was open to nonprofits.
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Is this a realistic fit?
- Past The U.S. President's Emergency Plan for AIDS Relief Programs awards averaged $146,897; this notice allows up to $15,000 per award.
- Most of the program's money (74% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The U.S. Embassy Kampala / PEPFAR Uganda Small Grants Office announces an open competition for organizations to submit applications for a community grants program to combat HIV/AIDS.
Who has won The U.S. President's Emergency Plan for AIDS Relief Programs grants before
From fiscal 2021 to 2025, The U.S. President's Emergency Plan for AIDS Relief Programs (19.029) awarded $117 million across 794 grant awards, an average of $146,897 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Maryland | 1 | $89.9 million |
| Miscellaneous Foreign Awardees | 321 | $7.9 million | |
| Ho Chi Minh City HIV/AIDS Association | 4 | $673,404 | |
| Tamra for Social Development Organization (TDS) | 3 | $638,998 | |
| National Empowerment Network of People Living with HIV / AIDS (Nephak) | 3 | $513,403 |
Applying now
This notice no longer takes applications. Apply under the newer notice, DFOP0017890, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is DOS-UGA-SMGCG-FY25 still open?
No. It closed on July 31, 2024. A newer notice is open: DFOP0017890, closes February 14, 2027 (99 days left).
Who can apply for PEPFAR Uganda Community Grants to Combat HIV/AIDS?
Bureau of African Affairs accepted applications from nonprofits.
What is the deadline for PEPFAR Uganda Community Grants to Combat HIV/AIDS?
Closed July 31, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $15,000 each. About $310,000 in total across about 15 awards.
Who has won The U.S. President's Emergency Plan for AIDS Relief Programs grants before?
The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Miscellaneous Foreign Awardees, Ho Chi Minh City HIV/AIDS Association. The program made 794 awards worth $117 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)